Acute myocardial infarction has long been the leading cause of death in coronary heart
disease, which is characterized by irreversible cardiomyocyte death and restricted blood …

Coronary artery disease (CAD) is the leading cause of mortality globally. Although
substantial advances have been made in the diagnosis, management, and risk stratification …

Regardless of the newly diagnostic and therapeutic advances, coronary artery disease
(CAD) and more explicitly, ST-elevation myocardial infarction (STEMI), remains one of the …

Existing markers of myocardial infarction have limited diagnostic value for infarction, so it is
necessary to identify new markers of infarction. To study the predictive value of serum …

Background: The no-reflow (NRF) phenomenon is the “Achilles heel” of interventionists after
performing percutaneous coronary intervention (PCI) in patients with ST-segment elevation …

This study attempted to identify exosomal circular RNAs (circRNAs) as diagnostic and
prognostic biomarkers for patients with ST-segment elevation myocardial infarction (STEMI) …

Cardiovascular diseases (CVDs) and cancer, which are the leading causes of mortality
globally, have been viewed as two distinct diseases. However, the fact that cancer and …

Methods: A literature search was conducted using PubMed and Web of Science for research
articles that investigated circulating miRNAs as prognostic tools following AMI, with an …

Objective: To compare the effectiveness of different tirofiban administration time windows in
patients with no-reflow myocardial infarction (MI) during percutaneous coronary intervention …

心肌梗死后主要不良心血管事件(major adverse cardiac events, MACEs) 不仅降低患者的生活
质量, 而且增加患者的死亡风险. 及时进行血液生物学标志物检测, 可预测心肌梗死后MACEs …